Doximity, Inc. [Rocket]

In millions, except per share items	Mar-31-23	Mar-31-22	Mar-31-21	Mar-31-20	Mar-31-19
	10-K	10-K	10-K	10-K	S-1/A
Revenues	419.1	343.5	206.9	116.4	0.8
Revenue growth	22.0%	66.0%	77.8%	15114.1%
Cost of goods sold	53.5	39.8	31.2	14.9	0.2
Gross profit	365.6	303.8	175.7	101.5	0.6
Gross margin	87.2%	88.4%	84.9%	87.2%	74.6%
Selling, general and administrative [+]	160.3	127.9	78.5	46.9	1.4
Sales and marketing	123.5	92.1	62.0	39.4	0.8
General and administrative	36.7	35.7	16.5	7.4	0.6
Research and development	80.2	62.4	43.9	32.4
Other operating expenses	-0.7
EBITDA [+]	136.1	118.6	57.0	23.1	-0.3
EBITDA growth	14.8%	108.0%	147.2%	-8902.7%
EBITDA margin	32.5%	34.5%	27.6%	19.8%	-34.2%
Depreciation	5.5	4.0	2.6	0.9	0.6
EBITA	130.6	114.5	54.4	22.2	-0.8
EBITA margin	31.2%	33.3%	26.3%	19.0%	-106.3%
Amortization of intangibles	4.8	1.0	1.1
EBIT [+]	125.8	113.5	53.3	22.2	-0.8
EBIT growth	10.8%	113.0%	140.5%	-2826.1%
EBIT margin	30.0%	33.0%	25.8%	19.0%	-106.3%
Non-recurring items	0.7
Other income (expense), net	8.0	0.5	4.5	1.4	0.8
Pre-tax income	133.2	114.0	57.8	23.5	0.0
Income taxes	20.3	-40.8	7.6	-6.2	0.0
Tax rate	15.3%		13.1%
Net income	112.8	133.3	21.6	10.8	0.0
Net margin	26.9%	38.8%	10.4%	9.3%	0.0%

Basic EPS [+]	$0.58	$0.82	$0.29	$0.16
Growth	-28.4%	181.1%	78.8%
Diluted EPS [+]	$0.53	$0.70	$0.23	$0.13
Growth	-24.2%	207.9%	71.0%

Shares outstanding (basic) [+]	193.2	163.5	74.3	66.8
Growth	18.2%	119.9%	11.4%
Shares outstanding (diluted) [+]	213.4	191.0	95.1	81.7
Growth	11.7%	100.8%	16.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.